Mizoram News Pulse
Buisness

Wall Street stocks decline as interest rates are raised by the Federal Reserve

After the Federal Reserve increased interest rates again on Wednesday, Wall Street stocks fell, but the central bank hinted it might hold off on further increases.

After a volatile session, the Dow Jones Industrial Average closed down 0.8 percent at 33,414.24.

The tech-heavy Nasdaq Composite Index fell 0.5 percent to 12,025.33, while the broad-based S&P 500 fell 0.7 percent to 4,090.75.

In a decision that was generally anticipated by observers, the Fed increased its benchmark lending rate for a tenth time in a row on Wednesday, by another quarter-point.

The central bank modified previous phrasing that implied more strongly that higher rates were coming by saying it will watch economic circumstances to decide whether further moves may be needed.

In a press conference, Fed Chair Jerome Powell said, “We feel like we're getting close, or maybe even there” in terms of raising interest rates enough to combat inflation.

However, Powell also said that interest rate reductions in 2023 were unlikely, which caused stocks to decline in the afternoon's final shift.

“It feels like the market didn't get everything it wanted but maybe got everything it could expect,” said Art Hogan, an analyst at B. Riley Financial, calling the move a “moderately dovish hike.”

However, Interactive Brokers' Steve Sosnick claimed that the market's decline was evidence that “people have been coming around to the general consensus that this was more hawkish than the dovish.”

Following recent bank failures, regional banking shares, which have been under pressure, ended the day lower, reversing earlier gains.

PacWest Bancorp sank by 2.0%, KeyCorp down by about two%, and Zions Bancorporation dropped by 5.3%.

Starbucks dropped 9.2 percent, among other businesses, after reporting better-than-expected profits and a cautious outlook that dismayed investors.

Following the publication of encouraging clinical data for a new treatment for early Alzheimer's disease, donanemab, Eli Lilly's share price increased by more than 6%.

Related posts

Due to a decline in income and other variables, Indian states are expected to fail their capital expenditure objectives this fiscal year

Infosys and HCL Tech will implement salary increases this quarter; see dates and other information

thousands of Cisco equipment are affected when a serious defect is used by hackers

In comparison to the US, purchasing an iPhone 15 is now less expensive in India. Here’s how

Authorities from the GST seize evidence of fraudulent transactions worth Rs. 134 billion in Agra

Price Increase: 40% Duty Placed Until December 31 On Onion Exports To Enhance Supply In Domestic Markets